Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Chesapeake Energy Offers a Juicy Play to Speculative Investors

By Chris Lau, InvestorPlace Contributor

Natural gas prices are at a multi-year low, keeping CHK stock at penny status. But a rebound in prices could bring double-digit gains.

7 5G Stocks to Buy Now for the Future

By Chris Lau, InvestorPlace Contributor

5G deployment is underway. Investors who ignore this trend are missing its potential as 5G growth accelerates in the next few years.

7 Autonomous Vehicle Stocks to Drive You to the Future

By Chris Lau, InvestorPlace Contributor

Technology firms are expanding beyond computer and mobile markets for growth. Autnomous vehicles are the next area driving the future.

Moderna Will Rebound, But Wait for a Dip Lower to Buy Shares

By Chris Lau, InvestorPlace Contributor

A secondary offering put downward pressure on Moderna stock that will soon ease up. But wait for a dip toward $15 to buy shares.

7 Micro-Cap Stocks That Could Double

By Chris Lau, InvestorPlace Contributor

Hidden gem micro-cap stocks are hard to find, unless savvy investors screen for value and strong revenue growth.

Load More